Maria G. Ciampa

Segrate, 20054, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

GM1 Oligosaccharide Modulates Microglial Activation and α-Synuclein Clearance in a Human In Vitro Model.

GM1 Oligosaccharide Modulates Microglial Activation and α-Synuclein Clearance in a Human In Vitro Model.

Journal: International journal of molecular sciences

Published: July 11, 2025

GM1 oligosaccharide-mediated rescue in GBA-linked Parkinson's disease via modulation of lysosomal and mitochondrial dysfunctions.

GM1 oligosaccharide-mediated rescue in GBA-linked Parkinson's disease via modulation of lysosomal and mitochondrial dysfunctions.

Journal: Glycoconjugate journal

Published: April 30, 2025

Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model.

Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model.

Journal: Biomedicines

Published: February 20, 2025

GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.

GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.

Journal: International journal of molecular sciences

Published: September 26, 2024

GM1 structural requirements to mediate neuronal functions.

GM1 structural requirements to mediate neuronal functions.

Journal: Glycoconjugate journal

Published: September 20, 2023

GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.

GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.

Journal: FEBS open bio

Published: July 19, 2023

GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.

GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: April 05, 2023

GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.

GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.

Journal: Biomedicines

Published: April 05, 2023

Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody.

Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody.

Journal: Neurochemical research

Published: August 20, 2022

Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions.

Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions.

Journal: FEBS letters

Published: April 06, 2022

Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease?

Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease?

Journal: The international journal of biochemistry & cell biology

Published: July 23, 2021

GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.

GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.

Journal: International journal of molecular sciences

Published: April 01, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026